Cargando…

Experience with procalcitonin use during the COVID-19 pandemic

Detalles Bibliográficos
Autores principales: Gonzalez, Laura, Holman, Thomas, Wait, Daniel, Abenojar, Pearl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008189/
https://www.ncbi.nlm.nih.gov/pubmed/35465971
http://dx.doi.org/10.1016/j.ejim.2022.04.002
_version_ 1784686994261016576
author Gonzalez, Laura
Holman, Thomas
Wait, Daniel
Abenojar, Pearl
author_facet Gonzalez, Laura
Holman, Thomas
Wait, Daniel
Abenojar, Pearl
author_sort Gonzalez, Laura
collection PubMed
description
format Online
Article
Text
id pubmed-9008189
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V. on behalf of European Federation of Internal Medicine.
record_format MEDLINE/PubMed
spelling pubmed-90081892022-04-14 Experience with procalcitonin use during the COVID-19 pandemic Gonzalez, Laura Holman, Thomas Wait, Daniel Abenojar, Pearl Eur J Intern Med Letter to the Editor Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. 2022-08 2022-04-14 /pmc/articles/PMC9008189/ /pubmed/35465971 http://dx.doi.org/10.1016/j.ejim.2022.04.002 Text en Crown Copyright © 2022 Published by Elsevier B.V. on behalf of European Federation of Internal Medicine. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Gonzalez, Laura
Holman, Thomas
Wait, Daniel
Abenojar, Pearl
Experience with procalcitonin use during the COVID-19 pandemic
title Experience with procalcitonin use during the COVID-19 pandemic
title_full Experience with procalcitonin use during the COVID-19 pandemic
title_fullStr Experience with procalcitonin use during the COVID-19 pandemic
title_full_unstemmed Experience with procalcitonin use during the COVID-19 pandemic
title_short Experience with procalcitonin use during the COVID-19 pandemic
title_sort experience with procalcitonin use during the covid-19 pandemic
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9008189/
https://www.ncbi.nlm.nih.gov/pubmed/35465971
http://dx.doi.org/10.1016/j.ejim.2022.04.002
work_keys_str_mv AT gonzalezlaura experiencewithprocalcitoninuseduringthecovid19pandemic
AT holmanthomas experiencewithprocalcitoninuseduringthecovid19pandemic
AT waitdaniel experiencewithprocalcitoninuseduringthecovid19pandemic
AT abenojarpearl experiencewithprocalcitoninuseduringthecovid19pandemic